EraGen Again Moving Multiplex Assays Toward Clinic in Wake of Luminex Separation

Following the dissolution last year of a longstanding relationship with Luminex, EraGen is once again eyeing the IVD market for its multiplex PCR assay reagents by partnering with other companies offering bead-based detection systems.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.